Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Magnus Ekström, MD, is a senior consultant, associate professor, and senior lecturer in Respiratory and Palliative Medicine at Lund University, Sweden. He is also head of the Swedish National Registry for Respiratory Failure (Swedevox). His main research focus is contributing factors, measurement and treatment of breathlessness. He also leads research in oxygen therapy and treatment in patients with chronic respiratory failure. He is involved in multicenter trials and international research collaborations, and lead projects across a range of research methodologies, including mechanistic, epidemiological and registry-based studies, clinical cohort studies, Cochrane meta-analyses, and randomized controlled trials.
Prof Morag Farquhar has worked in health services research for over 30 years, predominantly in palliative and supportive care. An early graduate nurse by background, graduating from King's College London, UK, she holds a Masters in medical sociology and PhD from the University of London, UK. Her research interests include breathlessness in advanced disease, palliative care, unpaid carers, chronic progressive disease, and methodology, particularly the development and testing of interventions and mixed methods. As Professor of Palliative Care Research in the School of Health Sciences at the University of East Anglia, UK, she leads a research programme on improving care and support for patients and carers living with advanced disease, including the Support Needs Approach for Patients programme (SNAP) and Learning about Breathlessness (LaB) programme. SNAP has developed an intervention to enable person-centred care for people with chronic or progressive conditions (https://thesnap.org.uk) and LaB has developed a web-based educational intervention for unpaid carers of patients with breathlessness (https://supporting-breathlessness.org.uk/).
Dr Kokorovic completed her undergraduate studies and a master's degree at the University of Toronto, Canada, followed by completing Medical School at Queen's University in Kingston, Ontario, Canada. She subsequently completed a urology residency at Dalhousie University in Halifax, Nova Scotia, Canada, followed by a fellowship in urologic oncology at The University of Texas MD Anderson Cancer Center, USA. She joined the University of Montreal, Canada, urology faculty as a urologic oncologist upon completing her fellowship in 2021. Her clinical and research interests include management of urologic cancers, with a focus on bladder, prostate, and kidney cancer. She is passionate about improving the lives of patients living with urological malignancies.
Fred Saad, MD FRCS is Professor and Chairman of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM), Canada. He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is the past Chair of the National Cancer Institute of Canada G-U Group and the Canadian Urologic Oncology Group. Dr Saad has been involved in most of the important clinical trials in advanced prostate cancer over the last 20 years and presently sits on 7 steering committees of international clinical trials. He serves on several international guidelines committees and sits on 7 editorial boards, including Lancet Oncology, JAMA Oncology, Nature Urology, and Urology, as well as Current Oncology. He has published over 400 peer-reviewed articles as well as over 1,500 scientific abstracts, 8 books and over 50 book chapters. With a h-factor of 96 and over 41,000 citations he was listed as one of the most cited scientists in 2017. Dr Saad's research interests include molecular prognostic markers, mechanisms of progression, and new therapeutics in prostate cancer. He has over 40 clinical and basic research projects ongoing and has received over 30 million dollars in research grants to date. In 2014 he received the lifetime achievement award from the CHUM Research Center and in 2017 received the outstanding contribution award from The Prostate Cancer Canada Network.